课题基金 / 基金详情

Cell and Molecular Cancer Research Training in Nevada

Cell and Molecular Cancer Research Training in Nevada
内华达州细胞和分子癌症研究培训
批准号:
7690976
负责人:
Dorothy Hudig
金额:
$3.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-08-01 至 2009-08-31

项目摘要

项目成果

Dorothy Hudig的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Nevada is the fastest-growing state in the nation. In 1986, a T32 grant to the University of Nevada, Reno provided two stipends for cancer research training within the new Cell and Molecular Biology (CMB) Graduate Program. Nevada's first biomedical training grant now supports four trainees per year, about 16% of the CMB predoctoral students. Dorothy Hudig, Ph.D., Professor of Immunology, directs the cancer research training program. There are 3 major changes in this competitive renewal. (1) Predoctoral training includes opportunities to participate in the NIH Graduate Partners Program. (2) With NCI program approval, a 5 year phase-in plan will add postdoctoral cancer research training and result in 25% predoctoral trainees (2 pre, 6 post) by the next competitive renewal. (3) The pro_am has established an extramural Advisory Committee for Postdoctoral Career Development, to make Nevada a siteto develop approaches for successful career advancement. Graduate students are selected for T32 support after advancement to candidacy; their cancer research training includes a Cell and Molecular Biology of Cancer Course, cancer research seminars and joumal clubs, exposure to oncology patients, and cancer-related thesis research. Seventeen students were supported by the last award; 13 graduates and 4 continuing students. They published 38 papers. The twelve T32 faculty sponsors are in 5 departments within 4 administrative units and have 29 extramural competitive grants, with an average of $297,000 annual direct costs per sponsor. Many of the postdoctoral trainees will enter with appointments promotable to research professors and will be helped to obtain the independent funding needed to develop their careers. Their training includes community-based cancer research training, such as attendance of tumor board presentations and an oncologyjournal club with the residents in internal medicine; training in job-related skills such as personnel management; and private career counseling.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
Characterization, application and potential uses of biotin-tagged inhibitors for lymphocyte serine proteases (granzymes).
淋巴细胞丝氨酸蛋白酶(颗粒酶)生物素标记抑制剂的表征、应用和潜在用途。
DOI: 10.1016/0161-5890(96)00025-9
发表时间: 1996
期刊: Molecular immunology
影响因子: 3.6
作者: [Winkler,U, Allison,NJ, Woodard,SL, Gault,RA, Ewoldt,GR, Kam,CM, Abuelyaman,A, Powers,JC, Hudig,D]
通讯作者: Hudig,D
DOI: 10.1038/sj.bjc.6604998
发表时间: 2009-05-05
期刊: BRITISH JOURNAL OF CANCER
影响因子: 8.8
作者: [Rumjahn, S. M., Yokdang, N., Baldwin, K. A., Thai, J., Buxton, I. L. O.]
通讯作者: Buxton, I. L. O.
cDNA cloning of granzyme J.
颗粒酶 J 的 cDNA 克隆
DOI: 10.1007/s002510050231
发表时间: 1997
期刊: Immunogenetics
影响因子: 3.2
作者: [Ewoldt,GR, Darcy,PK, Snook,MB, Hudig,D, Smyth,MJ]
通讯作者: Smyth,MJ
Histone-histone interaction mediates chromatin unfolding at physiological ionic strength.
组蛋白-组蛋白相互作用介导染色质在生理离子强度下展开。
DOI: 10.1021/bi00440a013
发表时间: 1989
期刊: Biochemistry
影响因子: 2.9
作者: [Riehm,MR, Harrington,RE]
通讯作者: Harrington,RE
14
    Risk of CFS Due to IgG Receptor Genes that Impair ADCC
    • 批准号:
      8876331
    • 项目类别:
    • 资助金额:
      $21.78万
    • 财政年份:
      2015
    • 负责人:
      Dorothy Hudig
    • 依托单位:
    FACULTY TRAINING CORE
    • 批准号:
      7610087
    • 项目类别:
    • 资助金额:
      $23.7万
    • 财政年份:
      2007
    • 负责人:
      Dorothy Hudig
    • 依托单位:
    FACULTY TRAINING CORE
    • 批准号:
      7381458
    • 项目类别:
    • 资助金额:
      $7.05万
    • 财政年份:
      2006
    • 负责人:
      Dorothy Hudig
    • 依托单位:
    GRANZYMES OF CYTOTOXIC LYMPHOCYTES
    国内基金
    海外基金
    Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
    • 批准号:
      81300605
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2013
    • 负责人:
      唐琳
    • 依托单位:
    Molecular Plant
    Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
    Molecular Plant